ClinicalTrials.gov
public full text
Public Domain
Comparison of Body Weight Change During Contraception With Belara and Yasmin
The purpose of this study is to evaluate different side effect in contraceptive use of two oral combined contraceptive pills (OCP)in combination of 30 mcg ethinylestradiol/2 mg chlormadinone acetate (Belara®) and 30 mcg ethinylestradiol/3 mg drospirenone (Yasmin®), especially body weight change.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Xinju Xiaogao Prescription Study on Overweight#1009910
- Study Evaluating Effects of Levonorgestrel and Ethinyl Estradiol on Ovulation#1149954
- Low Dose OC Therapy in Women With Polycystic Ovary Syndrome (PCOS): Impact of BMI on Hyperandrogenism#861344
- Diamel in the Treatment of Polycystic Ovary Syndrome#874814
- The OAT Trail: The Obesity Anti-Coagulation Thromboprophylaxis Trial.#892489
Record · ID 908013
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive